1.41439
Parteck® SRP 80 (Polyvinyl alcohol)
EMPROVE® ESSENTIAL, Ph. Eur., ChP, USP, JPE
別名:
Parteck® Polyvinyl alcohol, PVA, PVOH
製品名
Parteck® SRP 80 (Polyvinyl alcohol), EMPROVE® ESSENTIAL, Ph. Eur., ChP, USP, JPE
InChI
1S/C2H4O/c1-2-3/h2-3H,1H2
InChI key
IMROMDMJAWUWLK-UHFFFAOYSA-N
agency
ChP
JPE
Ph. Eur.
USP
product line
EMPROVE® ESSENTIAL
form
fine powder
particle size
60-100 μm (d50)
mp
160-240 °C
application(s)
controlled release
pharmaceutical
solid formulation
storage temp.
15-25°C
Quality Level
類似した製品をお探しですか？ 訪問 製品比較ガイド
Application
Parteck® SRP 80, a functional, fully synthetic excipient based on polyvinyl alcohol (PVA), provides consistent, sustained drug delivery over long release periods. Due to its optimized particle properties, Parteck® SRP 80 excipient has a high compressibility and high dilution potential as well as reliable in-vitro drug dissolution.
Features and Benefits
- Reliable sustained release profiles of active pharmaceutical ingredients over several hours
- Suitable for direct compression processes with conventional equipment
- Resistant to pH- and alcohol-induced dose dumping
- Superior batch-to-batch consistency and robust performance due to fully synthetic material
General description
With formulation challenges in mind, we have used particle engineering technologies to develop functional excipients specifically for solid dosage forms. The products in our Parteck® portfolio feature unique particle properties tailored for excellent performance in tableting processes, for specific drug delivery technologies, or for solubility enhancement.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.
Legal Information
Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
PARTECK is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany
保管分類
11 - Combustible Solids
wgk
WGK 1
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Substances Subject to be Indicated Names
ishl_indicated
Substances Subject to be Notified Names
ishl_notified
CO1E1414391000: + 1414391000: + 1414399025: + 1414399025BWT: + 1414390000: + CO1I1414391000: + 1414391000BWT: + CO1E1414399025:
jan
試験成績書（COA）
製品のロット番号・バッチ番号を入力して、試験成績書（COA） を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
グローバルトレードアイテム番号
| カタログ番号 | GTIN |
|---|---|
| 1.41439.9025 | 04027269958039 |
| 1.41439.1000 | 04027269957407 |
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）